Evidence map›Paper›PMID 20138279›Full record

ArticleAtherosclerosis2010

Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007.

Christian Delles, Jane A Dymott, Ulf Neisius, J Paul Rocchiccioli, Gavin J Bryce, María U Moreno, David M Carty, Geoffrey A Berg, Carlene A Hamilton, Anna F Dominiczak

Open access · greenAbstract read
In one paragraph

Article in Atherosclerosis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Impact of Climate Change on Cardiovascular Health.Current atherosclerosis reports · 2024
    Review
  4. Review
  5. The Role of Inflammation in Cardiovascular Disease.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Statins and vein graft failure in coronary bypass surgery.Current opinion in pharmacology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Christian DellesBHF Glasgow Cardiovascular Research Centre, Faculty of Medicine, University of Glasgow, and Department of Vascular Surgery, Gartnavel General Hospital, 126 University Place, Glasgow G12 8TA, Scotland, UK. c.delles@clinmed.gla.ac.uk
Jane A Dymott
Ulf Neisius
J Paul Rocchiccioli
Gavin J Bryce
María U Moreno
David M Carty
Geoffrey A Berg
Carlene A Hamilton
Anna F Dominiczak
University of Glasgow · GBGartnavel General Hospital · GBWestern Infirmary · GB

Funding

British Heart Foundation BHF RG/07/005/23633
6 · The paper itself

Abstract

objectiveRecent guidelines recommend more aggressive lipid-lowering in secondary prevention protocols. We examined whether this resulted in improved endothelial function.

methodsWe studied saphenous vein specimens of patients undergoing surgical coronary revascularisation in 2007 and compared results with those of patients examined in 2003. Endothelium-dependent vasodilation was assessed by relaxation to calcium ionophore A23187, and vascular superoxide production by lucigenin enhanced chemiluminescence.

resultsStatin dose increased from 26+/-16 mg/d in 2003 to 37+/-17 mg/d in 2007 (P<0.001), and total (4.0+/-0.9 mmol/L vs 4.8+/-1.0 mmol/L) and LDL-cholesterol levels (2.0+/-0.7 mmol/L vs 3.0+/-0.9 mmol/L) were lower in 2007 compared to 2003 (P<0.001; n=90 each). Endothelium-dependent vasodilation was greater in 2007 (44+/-15%) compared to 2003 (28+/-12%; n=36 each; P<0.001). Vascular superoxide derived from endothelial NO synthase (eNOS) was lower in 2007 than in 2003 (reduction by NG-nitro-L-arginine-methyl ester, 0.29+/-0.21 nmol/(mg min) vs 0.09+/-0.20 nmol/(mg min); P=0.002). In linear regression analysis, LDL-cholesterol levels have been shown to be the major determinant of endothelial function in the combined 2003 and 2007 cohort.

conclusionIntensive lipid-lowering is associated with improved endothelial function and reduced superoxide production from eNOS. Further improvement in vascular function could be achieved by targeting other sources of superoxide including xanthine oxidase.

Indexed as

AgedCholesterol, LDLCoronary Artery DiseaseEndotheliumFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedNitric Oxide Synthase Type IIISuperoxidesCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsNitric Oxide Synthase Type IIINOS3 protein, humanSuperoxides

Identifiers

PMID20138279
PMCPMC2946556
OpenAlexW2046754110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.